BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 110 found
  Current Search:  cardizem: 110     

HTML
100%
If Biovail action fails, Melnyk vows to start new drug firm
TORONTO - The fog of confusion around Biovail Corp.

deepened Wednesday as founder and former chairman Eugene Melnyk, now the head of a dissident shareholder group, announced he will launch a new drug company but only if he fails in his bid...

New Brunswick Business Journal:  Jun 26 2008 10:50PM
Matching: cardizem
Find similar documents
HTML
100%
Court likely next stop for Biovail battle
Shareholders back board; Melnyk pulls votes in protest More On This Story Story Tools -+ Change font size Share This Story Story tools presented by Peter Jones/ReutersBiovail Corp.

expects its founder Eugene Melnyk to take his battle for...

Financial Post:  Jun 25 2008 5:37PM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk keeps on fighting
Mark Blinch, ReutersBATTLE FOR BIOVAIL HEADED FOR COURT: Biovail company founder and majority shareholder Eugene Melnyk yesterday announced plans for a new drug company after his attempt to replace Biovail's board of directors ...

The fog...

Financial Post:  Jun 26 2008 8:37AM
Matching: cardizem
Find similar documents
HTML
100%
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and
Leading Drug Delivery Companies and Technologies Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business decisions.
Canadian Business Magazine:  Jun 23 2008 10:59PM
Matching: cardizem
Find similar documents
HTML
100%
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and
Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is...
Houston Chronicle:  Jun 23 2008 8:11PM
Matching: cardizem
Find similar documents
HTML
100%
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and
Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is...
Market Wire:  Jun 23 2008 7:56PM
Matching: cardizem
Find similar documents
HTML
100%
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and
Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments http://www.reportlinker.com/p090379/Leading-Drug-Delivery-Companies-and-Technologies-Competitive-landscape-company...
Calibre Macro World:  Jun 23 2008 7:54PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail declines after generic threats, development questions lead to downgrade
NEW YORK (AP) - Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is shifting its focus...

Canadian Business Magazine:  Jun 20 2008 10:19PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
NEW YORKShares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.Biovail is shifting its focus to central...

Boston Globe:  Jun 20 2008 9:51PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
NEW YORK - Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is shifting its focus to...

CNBC:  Jun 20 2008 8:36PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail declines after generic threats and development questions lead to analyst downgrade
- 3:08 p.m.

NEW YORK (AP) - Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is...

Canadian Business Magazine:  Jun 20 2008 7:23PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is shifting its focus to central...

Business Week:  Jun 20 2008 7:18PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
NEW YORK (AP) - Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is shifting its focus...

Financial Times via MSN Money:  Jun 20 2008 7:18PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail (nyse: BVF - news - people ) is...

Forbes.com:  Jun 20 2008 7:17PM
Matching: cardizem
Find similar documents
HTML
100%
Biovail stock falls after analyst cuts rating
NEW YORK (AP) -- Shares of drug developer Biovail Corp.

sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.

Biovail is shifting its focus...

Yahoo! Canada:  Jun 20 2008 7:10PM
Matching: cardizem
Find similar documents
HTML
100%
Challenger wants debate with Biovail CEO
TORONTO The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug companys current chief executive to a debate in the latest move in a proxy fight between Biovails current management and Melnyk.

In a...

Ottawa Sun:  Jun 18 2008 8:47PM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

The Mix:  Jun 17 2008 2:03PM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
- 7:05 pm TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and...

660 News:  Jun 17 2008 1:45PM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

Sympatico MSN Finance:  Jun 17 2008 9:07AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO, The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In a...

Macro World Investor:  Jun 17 2008 8:57AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
AMTORONTO, The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In a...

Calibre Macro World:  Jun 17 2008 8:57AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

QX104 FM:  Jun 17 2008 7:37AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

Macleans Online:  Jun 17 2008 7:19AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

CJFW:  Jun 17 2008 5:32AM
Matching: cardizem
Find similar documents
HTML
100%
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate
TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.

(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.

In...

The Team 1260:  Jun 17 2008 5:08AM
Matching: cardizem
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.